Green Thumb Industries (GTBIF) Interest & Investment Income (2019 - 2026)
Green Thumb Industries (GTBIF) posted Interest & Investment Income of $4.6 million for Q1 2026, up 13.82% on a QoQ basis from $4.0 million in Q4 2025, and up 116.82% year-over-year from $2.1 million in Q1 2025.
Green Thumb Industries (GTBIF) Interest & Investment Income (2019 - 2026) Analysis & Trends
Green Thumb Industries' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- Quarterly Interest & Investment Income rose 116.82% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (up 52.38% YoY) and the FY2025 annual result came in at $11.4 million, up 25.38% from the prior year.
- Interest & Investment Income was $4.6 million for Q1 2026 at Green Thumb Industries, up from $4.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.6 million in Q1 2026 and bottomed at $624000.0 in Q2 2022.
- A 5-year average of $2.1 million and a median of $1.9 million in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 1700.0% — and 2025, when it dropped 17.46%.
- Green Thumb Industries' Interest & Investment Income stood at $1.5 million in 2022, then climbed by 27.24% to $1.9 million in 2023, then gained by 7.15% to $2.0 million in 2024, then jumped by 103.01% to $4.0 million in 2025, then advanced by 13.82% to $4.6 million in 2026.
- Business Quant data shows GTBIF's Interest & Investment Income at $4.6 million in Q1 2026, $4.0 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 4.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 624,000.00 |
| Mar 31, 2022 | 900,000.00 |
| Dec 31, 2021 | 758,000.00 |
| Sep 30, 2021 | 328,000.00 |
| Jun 30, 2021 | 296,000.00 |